Fractyl Health (GUTS) Tests Whether Revita Can Redefine Post-GLP-1 Weight Maintenance Economics [Yahoo! Finance]
Fractyl Health, Inc. (GUTS)
Company Research
Source: Yahoo! Finance
procedure for weight maintenance after GLP-1 drug discontinuation, and is seeking FDA feedback on a potential De Novo regulatory pathway. The company has laid out a packed 2026 roadmap of clinical readouts and regulatory milestones for Revita, signaling a clearer path toward potential U.S. marketing submission in post-GLP-1 weight maintenance. We will now examine how the encouraging REMAIN-1 Midpoint data and De Novo pathway discussions could reshape Fractyl Health's investment narrative. The latest GPUs need a type of rare earth metal called Dysprosium and there are only 33 companies in the world exploring or producing it . Find the list for free. To own Fractyl Health, you have to believe Revita can earn a meaningful role in post-GLP-1 weight maintenance and that the company can finance itself long enough to reach that point. The new six-month REMAIN-1 Midpoint data and the request to move Revita onto a De Novo pathway materially sharpen the near-term story: 2026 is now more
Show less
Read more
Impact Snapshot
Event Time:
GUTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GUTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GUTS alerts
High impacting Fractyl Health, Inc. news events
Weekly update
A roundup of the hottest topics
GUTS
News
- Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – GUTSBusiness Wire
- Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation [Yahoo! Finance]Yahoo! Finance
- Fractyl Health (NASDAQ:GUTS) was downgraded by analysts at Morgan Stanley to a "cautious" rating.MarketBeat
- Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – GUTSBusiness Wire
- Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage PreparednessGlobeNewswire
GUTS
Earnings
- 3/3/25 - Miss
GUTS
Sec Filings
- 1/14/26 - Form 4
- 1/14/26 - Form 3
- 1/13/26 - Form S-8
- GUTS's page on the SEC website